author-photo

Tamer Garawin

Amgen

18

Papers

102

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis: a retrospective evaluation using Medicare claims

2019 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (4)
Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma

2019 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (7)
Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis

2019 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (24)
An assessment of KRAS, NRAS, and BRAF testing prior to 1st line of therapy among mCRC patients treated at community cancer centers in the United States.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Prevalence of RAS and BRAF mutations in metastatic colorectal cancer (mCRC) patients by tumor location.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A survey of medical oncologist’s opinions and perceptions regarding the management of dermatologic toxicities among mCRC patients treated with panitumumab in the United States.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
RAS mutation prevalence among patients with metastatic colorectal cancer: A meta-analysis of real-world data

2017 Biomarkers in Medicine
Show All
- Source
- Cite
- Save
Citations (18)
Regional and practice setting differences in the management of EGFR rash among mCRC patients treated with panitumumab: Results of a national survey in the United States.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The treatment continuum of panitumumab, cetuximab, and bevacizumab in 1st through 3rd line by KRAS, NRAS, and BRAF mutation status among mCRC patients treated at community cancer centers in the United States.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Preemptive versus reactive management of EGFR rash among mCRC patients treated with panitumumab: Results of a national survey of treating oncologists in the United States.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)